A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
Open label, two year study of the clinical efficacy of the combination of FTC, Tenofovir, and
Nevirapine. Sixty HIV infected patients without previous exposure to antiretroviral therapy
will be enrolled. Study will include a pharmacokinetic substudy to evaluate the interaction
of FTC and Nevirapine. Truvada may be used.
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore University of Maryland, College Park